An observational study in Fractures, Bone, sponsored by Artoss Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Artoss Inc. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 192 studies in Fractures, Bone with a site in United States — 37 open to participants now, 43 under way, 2 of them phase 3. Fractures, Bone · United States.
Among the 192 studies in Fractures, Bone with a site in United States, this one is the 19th largest by planned enrollment of the 63 observational ones that give a count, is one of 7 that started in 2023, is one of 63 observational ones, reaches primary completion later than 12 of the 42 other live ones, and was the 170th registered.
725 studies on the registry are indexed under Fractures, Bone; 116 are open to participants now.
Browse Fractures, Bone studies →37 of the 192 studies in Fractures, Bone with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 6–17
Amber Implants B.V. · Sites in United States
Ages 21–85
BoneVue Diagnostics · Sites in United States
Ages 30–90
The Cooper Health System · Sites in United States
Ages 65+
Mayo Clinic · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 73 Fractures, Bone studies recruiting now, 36 (49%) set no upper age limit and 23 (32%) stop at 75 or younger; 18 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
192 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 27 · Phase 3 21 · Phase 4 19
First in 1991; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 130 across 241 observational studies indexed under Fractures, Bone.
Median enrollment 87 across the 129 interventional studies, 100 across the 63 observational. Of the 134 that completed or were terminated, 54 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
48 of 192 have an industry lead sponsor. The 10 most frequent:
Artoss Inc. is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Artoss Inc. has 1 study filed under Fractures, Bone — fewer than ten, so there is no comparison to draw.
15 of the studies in Fractures, Bone with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05699174Phase 3Major Extremity Trauma Research ConsortiumPO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation | 2027-09 |
| NCT05824676Hartford HospitalDePuy Synthes Variable Angle LCP Patella Plating System Study | 2026-12 |
| NCT07430345The Cooper Health SystemBuprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department | 2026-12 |
| NCT06256458Artoss Inc.Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma | 2026-12-01 |
| NCT04921865AO Innovation Translation CenterCase Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems | 2027-01-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 192 studies in Fractures, Bone with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
The primary objective of this study is to document and analyze the use of NanoBone products in acute trauma cases (as a stand-alone bone graft, or in combination with local bone only, no other bone graft substitute or biologic product used) and determine both radiographic success and clinical outcomes. All product related adverse events will be documented, tabulated, and summarized.
All patients in the study will be drawn from the individual surgeons' practice. Patients will be among those already surgically treated for trauma but have not completed their standard of care follow-up as determined by the surgeon's practice. In addition, the surgeon had determined that the use of a NanoBone product was clinically necessary for the patient. The choice of a NanoBone product was independent of this research project. Only patients who have had NanoBone implanted and consent to participate and meet the inclusion-exclusion criteria will be included in the registry.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Acute fractures, resulting from blunt or penetrating trauma
Exclusion Criteria:
Certain fracture locations (these apply to non-unions as well)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The surgical technique used by the surgeon and the choice of the specific NanoBone product is or was determined solely by the surgeon and is independent of this observational study.
Radiographic evidence of fracture healing
AP and lateral x-rays
Time frame: 2 weeks, 6 weeks, 3 months, 6 months
Pain relief
Visual Analog Scale (VAS) pain score at fracture site. 0-10 scale, lower score means less pain.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.
Of 87 observational studies under Fractures, Bone, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 124. This study's planned 36 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.